Follow-up of early stage melanoma: Specialist clinician perspectives on the functions of follow-up and implications for extending follow-up intervals

Journal of Surgical Oncology

Volumn 107, Issue 5, 2013, Pages 463-468

  Rychetnik, Lucie ^a   McCaffery, Kirsten ^a   Morton, Rachael L ^a   Thompson, John F ^b,c,d,e   Menzies, Scott W ^b,e   Irwig, Les ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c MELANOMA INSTITUTE AUSTRALIA   (Australia)

^d Mater Hospital   (Australia)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

follow up; interval; melanoma; monitoring schedule

Indexed keywords

ANXIETY DISORDER; AUSTRALIA; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOLOGIST; FEMALE; FOLLOW UP; HEALTH CARE ORGANIZATION; HUMAN; MALE; MELANOMA; NURSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; REVIEW; SELF CARE; SURGEON;

ANXIETY; AUSTRALIA; CONTINUITY OF PATIENT CARE; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MELANOMA; NEEDS ASSESSMENT; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT EDUCATION AS TOPIC; PATIENT PREFERENCE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; SELF-EXAMINATION; SKIN NEOPLASMS;

EID: 84875236796     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23278     Document Type: Review

References (23)

1. Balch CM, Gershenwald JE, Soong SJ, et al.: Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-6206.
2. Francken AB, Bastiaannet E, Hoekstra HJ,: Follow-up in patients with localised primary cutaneous melanoma. Lancet Oncol 2005; 6: 608-621.
3. Speijers MJ, Francken AB, Hoekstra-Weebers JE, et al.: Optimal follow-up for melanoma. Exp Rev Dermatol 2010; 5: 461-478.
4. Hoekstra HJ, Francken AB,: MELFO-STUDY protocol: Prospective randomized trial for the evaluation of a theoretical follow-up schedule in cutaneous melanoma patients. 2007; http://dissertations.ub.rug.nl/FILES/faculties/ medicine/2007/a.b.francken/melfo.pdf. Accessed 17 March 2012.
5. Marsden JR, Newton-Bishop JA, Burrows L, et al.: Revised UK guidelines for the management of cutaneous melanoma. Br J Dermatol 2010; 163: 238-256.
6. Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical practice guidelines for the management of melanoma in Australia and New Zealand (follow-up, Chapter 19). Wellington: Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand Guidelines Group; 2008.
7. Fields RC, Coit DG,: Evidence-based follow-up for the patient with melanoma. Surg Oncol Clin N Am 2011; 20: 181-200.
8. Sondak VK, Leachman SA,: Individualizing follow-up for patients with early-stage melanoma. J Clin Oncol 2011; 29: 4606-4608.
9. Nieweg OE, Kroon BB,: The conundrum of follow-up: Should it be abandoned? Surg Oncol Clin N Am 2006; 15: 319-330.
10. Francken AB, Shaw HM, Accortt NA, et al.: Detection of first relapse in cutaneous melanoma patients: Implications for the formulation of evidence-based follow-up guidelines. Ann Surg Oncol 2007; 14: 1924-1933.
11. Francken AB, Accortt NA, Shaw HM, et al.: Follow-up schedules after treatment for malignant melanoma. Br J Surg 2008; 95: 1401-1407.
12. Turner RM, Bell KJL, Morton R, et al.: Optimizing the frequency of follow up visits for patients treated for localised primary cutanous melanoma. J Clin Oncol 2011; 29: 4641-4646.
13. Rychetnik L, McCaffery K, Morton RL, et al.: Psychosocial aspects of routine follow-up for stage I/II melanoma: A systematic review of the literature. Psychooncology 2012; Published ahead of print on 12 March as DOI: 10.1002/pon.3060
14. Bossuyt PMM, McCaffery K,: Additional patient outcomes and pathways in evaluations of testing. Med Decis Making 2009; 29: E30-E38.
15. Ferrante di Ruffano L, Hyde CJ, McCaffery KJ, et al.: Assessing the value of diagnostic tests: A framework for designing and evaluating trials BMJ 2012; 2012: 344.
16. Murchie P, Delaney EK, Campbell NC, et al.: GP-led melanoma follow-up: The practical experience of GPs. Fam Pract 2009; 26: 317-324.
17. Murchie P, Delaney EK, Campbell NC, et al.: GP-led melanoma follow-up: Views and feelings of patient recipients. Support Care Cancer 2010; 18: 225-233.
18. Murchie P, Nicolson MC, Hannaford PC, et al.: Patient satisfaction with GP-led melanoma follow-up: A randomised controlled trial. Br J Cancer 2010; 102: 1447-1455.
19. Hall SJ, Samuel LM, Murchie P,: Toward shared care for people with cancer: Developing the model with patients and GPs. Fam Pract 2011; 28: 554-564.
20. Charmaz K,: Constructing Grounded Theory: A practical guide through qualitative analysis. London: Sage Publications; 2006.
21. Pope C, Mays N,: Reaching the parts other methods cannot reach - An introduction to qualitative methods in health and health-services research. Br Med J 1995; 311: 42-45.
22. The Cancer Institute NSW. Dark side of tanning. 2012; http://www.darksideoftanning.com.au/campaign/campaign.aspx. Accessed 28 February
23. Morton RL, Rychetnik L, McCaffery K, et al.: Patients' perspectives of long-term follow-up for localised cutaneous melanoma. Unpublished data.